UK ’s CRT Pioneer Fund to invest in new blood cancer drugs

UK ’s Cancer Research Technology (CRT) Pioneer Fund has announced an investment to develop a new class of drugs for blood cancer, which will target a protein called B-cell lymphoma 6 (BCL6).
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news